Rehovot, Israel
September 20, 2004
Evogene Ltd., a pioneer in
plant biotechnology, and
Zeraim Gedera, a leading Israeli seed company, today
announced the signature of a collaboration agreement for the
joint development and commercialization of salt tolerant tomato
rootstocks and seed varieties.
The collaboration includes the
joint development by the partners of tomato lines tolerant to
high salinity levels. The leading tomato growing areas in the
world such as California and the Mediterranean area rely heavily
on irrigation. Due to massive irrigation practice and the use
of water sources with increasing salinity levels, many of these
major growing areas are becoming affected by accumulated soil
salinity, which requires the development of tomato lines with
good performance in these conditions.
The project will make use of
tomato genetic material pre-selected by Evogene through its
unique high throughput system, which enables the selection of
plants highly tolerant to salinity. The partners will jointly
develop high salinity tolerant tomato lines with the required
commercial performance. The partners will also use Evogene’s
genomic marker discovery using its computational genomics
capabilities to track the salinity performance of the developed
products.
Zeraim Gedera will be responsible
for the breeding of the varieties and rootstocks by contributing
its existing commercial tomato germplasm and implementing its
extensive breeding experience. Zeraim Gedera will also take
care of producing the seed and marketing the developed tomato
varieties in the target markets.
Ofer Haviv, COO for Evogene, stated:
“We are very pleased to enter into this cooperation with a
company with established leading tomato marketing capabilities.
This cooperation validates Evogene’s business model to become a
leading provider of improved plant traits together with seed
companies”.
Ohad Zuckerman, CEO of Zeraim
Gedera stated: “This project is a great example of synergy
between companies with complementing capabilities. Initially, we
planned to enter this market by ourselves, using traditional
breeding. By joining hands with Evogene we believe our return on
investment will be better since Evogene’s technology will
shorten our time-to-market”.
Evogene Ltd. mission is to become
a leading developer of ‘improved trait plants’ via a proprietary
platform combining state-of-the-art computational genomics,
molecular biology and advanced classical breeding methods. This
objective is accomplished through the development of
high-throughput, economically efficient platforms that
accelerate, direct and mimic the natural evolution process.
Evogene’s current research efforts are
focused in three areas: key trait improvements in cotton; gene
discovery for abiotic stress tolerance and plant nutrient
uptake; and a proprietary platform for the production of
therapeutic proteins in plants. Initiated in 1999 as a division
of Compugen (NASDAQ: CGEN); Evogene was established as a
separate company in 2002 by Compugen and founders Drs.
Hagai Karchi and Rafi Meissner.
Zeraim Gedera established in 1952, breeds high
quality vegetable varieties and markets the seeds of such
varieties worldwide. Company’s breeding programs are aimed at
developing fruit qualities attractive to consumers such as
specific visual traits, long shelf life, superior taste and
nutritional values together with traits important to the growers
such as high yield and resistance to various diseases and pests.
Zeraim Gedera maintains a very strong IP position in Tomato
developments. The Company is a “green” company, which uses
Biotechnology as a tool to upgrade its present and future R&D
activities but does not breed transgenic varieties. Zeraim
Gedera focuses on the “high end” of both the growers and the
consumers in various markets in the Mediterranean Basin, China,
North America and selected markets in South America and Asia. |